Granules India (GRANULES) Share Price Falls 2.18% in Latest Session
- September 2, 2026
- Posted by: Kunal Singla
- Category: News
Granules India Share Price was at Rs 848.80, down 2.18% at the latest reading, while the company carried a market capitalisation of Rs 23,163.10 crore. The move places Granules India Share Price in focus for investors tracking healthcare stocks, especially because the decline came after a relatively firm opening and an intraday range that stayed close to the lower end by the latest timestamp. Univest data confirms the move itself, though no company-specific trigger has been identified. Granules India Share Price Today therefore reflects a clear intraday weak patch in a Large Cap pharmaceutical name, and the latest Univest figures show a session that investors may want to read alongside valuation, profitability and sector comparison rather than as a standalone price move. Granules India Stock News also remains important for anyone monitoring how the stock behaves versus its healthcare peers.
Granules India (GRANULES) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 848.8 |
| Previous Close | Rs 867.7 |
| Today's Move | -Rs 18.90 (-2.18%) |
| Open | Rs 867.7 |
| High | Rs 884.15 |
| Low | Rs 848.45 |
| Market Capitalisation | Rs 23,163.1 crore |
| Market Cap Category | Large Cap |
Granules India Share Price today was Rs 848.80 against the previous close of Rs 867.70, marking a fall of Rs 18.90 or 2.18%. The stock opened at Rs 867.70, touched a high of Rs 884.15 and a low of Rs 848.45 during the latest session. That price action shows Granules India Share Price moved from the opening level into a softer zone by the latest timestamp, with the day’s low sitting very close to the current price. Granules India Share Price Today is being watched as a Large Cap stock with a market capitalisation of Rs 23,163.10 crore, and that company size matters when investors compare one session’s decline with broader market behaviour. In Granules India Stock News terms, the movement is factual and direct: the share price fall is confirmed, the range is defined and the latest reading sits near the session low. That sets up the fundamental question next.
Granules India (GRANULES) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 23,163.1 crore |
| P/E Ratio | 35.74x |
| P/B Ratio | 4.83x |
| ROE | 14.13% |
| ROCE | 15.74% |
| EPS | Rs 24.28 |
| Book Value Per Share | Rs 179.7 |
| Dividend Yield | 0.2% |
Granules India Share Price can be better understood through valuation and profitability metrics rather than the day’s fall alone. The stock trades at a P/E ratio of 35.74 and a P/B ratio of 4.83, with ROE at 14.13% and ROCE at 15.74%. EPS stands at Rs 24.28, book value is Rs 179.70 per share and dividend yield is 0.2%. These figures show that Granules India Share Price is being assessed at a valuation above the same-industry median on earnings and above the median on book value, while profitability remains positive but not extreme versus select healthcare leaders. Granules India Share Price News often turns on whether valuation, profitability and company earnings align, and the latest Univest figures give investors a concise context: the stock has solid return ratios, a moderate dividend yield and a valuation that deserves comparison with peers. Granules India Stock Analysis is therefore not just about the price move; it is about how the market may be reading earnings power, asset backing and returns together.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 35.74x |
| Benchmark Median P/E | 32.43x |
| Benchmark Average P/E | 49.46x |
| Benchmark P/E Range | 3.4x to 699.02x |
| Company P/B Ratio | 4.83x |
| Benchmark Median P/B | 2.89x |
| Benchmark Average P/B | 4.38x |
| Company ROE | 14.13% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 15.74% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 23,163.1 crore |
| Benchmark Median Market Cap | Rs 776.09 crore |
| Benchmark Average Market Cap | Rs 14,255.4 crore |
Granules India Share Price needs to be read against the Healthcare sector and the Pharmaceuticals & Drugs industry, where the benchmark scope covers 199 companies in the same industry. The company’s P/E of 35.74 is above the benchmark median of 32.43 and below the benchmark average of 49.46, which places Granules India Share Price in the middle-to-higher part of the range without being an outlier. On P/B, the company’s 4.83 is above the median of 2.89 and above the benchmark average of 4.38, suggesting a richer book-value multiple than many peers in the same industry. ROE at 14.13% is above the benchmark median of 11.7% and above the benchmark average of 10.68%, while ROCE at 15.74% is above the benchmark median of 13.61% and above the benchmark average of 13.4%. The benchmark market capitalisation median is Rs 776.09 crore and the average is Rs 14,255.40 crore, so Granules India Share Price sits in a Large Cap company that is materially larger than the typical same-industry name. This is the core sector context investors use when they judge whether Granules India Share Price is expensive, fairly placed or comparatively stronger on returns.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,41,477.63 | 36.9 | 5.16 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,031.38 | 85.99 | 14.24 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,85,216.32 | 85.72 | 20.83 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,20,897.46 | 26.42 | 4.42 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,205.15 | 33.15 | 3.18 | 11.83 | 16 |
Granules India Share Price can be compared with healthcare peers on valuation, profitability and size. Sun Pharmaceutical Industries has a P/E of 36.9, P/B of 5.16, ROE of 14.85% and ROCE of 19.11%, with a market cap of Rs 4,41,477.63 crore. Divi’s Laboratories shows a much higher P/E of 85.99 and P/B of 14.24, with ROE of 16.19% and ROCE of 21.51%, while Torrent Pharmaceuticals has a P/E of 85.72 and P/B of 20.83, supported by ROE of 26.76% and ROCE of 19.27%. Zydus Lifesciences trades at a P/E of 26.42 and P/B of 4.42, with ROE of 19.69% and ROCE of 21.39%. Against this group, Granules India Share Price sits below the very rich multiples of Divi’s and Torrent on earnings, but above Zydus on P/E and slightly above Zydus on P/B. That mix keeps Granules India Share Price in a valuation band that is neither the lowest-valued nor the most demanding among healthcare names. Univest data also shows that the company’s ROE and ROCE are healthy, though some peers deliver stronger return metrics.
Why Investors Are Watching Granules India
- Granules India Share Price is down 2.18% in the latest session, so the immediate price action is central to tracking Granules India Stock News.
- The stock is a Large Cap name with a market capitalisation of Rs 23,163.10 crore, which gives the move more relevance for sector watchers.
- Granules India Share Price carries a P/E of 35.74 and a P/B of 4.83, so valuation remains part of the discussion.
- ROE at 14.13% and ROCE at 15.74% give Granules India Fundamental Analysis a profitability base to compare with healthcare peers.
- The company sits in the Healthcare sector and Pharmaceuticals & Drugs industry, where peer valuation gaps remain wide.
About Granules India
Granules India operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Granules India Share Price is followed because the company belongs to a group of listed pharmaceutical names that are often compared on earnings power, book value and return ratios. Granules India Stock News is also relevant for investors who watch Large Cap healthcare companies with measurable valuation discipline. The company description provided through Univest data identifies the business within this industry framework, and the stock’s market position should be read in that context. Granules India Share Price today, therefore, is not only an intraday move; it is part of a broader market view of a healthcare company that is already large enough to be benchmarked against some of the sector’s most widely tracked names.
Track Granules India Share Price on Univest
Use Granules India (GRANULES) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Investors can track Granules India Share Price on Univest for live price updates, fundamental ratios, 52-week levels and market insights. Granules India Share Price Today can be followed alongside sector comparison, peer positioning and company-specific valuation metrics in one place. Univest also helps users review Granules India Stock News and Granules India Share Price Update without moving across multiple sources. For anyone watching Granules India Share Price News, the platform keeps the core numbers organised and easy to check.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Granules India Share Price fall today?
Ans. Granules India Share Price fell 2.18% to Rs 848.80 in the latest reading. According to Univest data, the price event is confirmed, but no company-specific catalyst is established, so the move should be read as verified price action only.
What is Granules India Share Price today?
Ans. Granules India Share Price was Rs 848.80 at the latest timestamp. That compares with the previous close of Rs 867.70, so the stock was trading Rs 18.90 lower in the session.
How much did Granules India Share Price change today?
Ans. Granules India Share Price declined by Rs 18.90, or 2.18%, versus the previous close. The day’s opening level was Rs 867.70, while the latest low touched Rs 848.45. The intraday range extended from Rs 848.45 to Rs 884.15.
Is Granules India Share Price a Large Cap stock?
Ans. Yes, Granules India Share Price belongs to a Large Cap company with a market capitalisation of Rs 23,163.10 crore. That size makes the latest session’s move more relevant in healthcare stock tracking.
What are the key valuation ratios for Granules India Share Price?
Ans. Granules India Share Price is valued at a P/E ratio of 35.74 and a P/B ratio of 4.83. Those numbers place it above the same-industry median on both earnings and book-value multiples.
How does Granules India compare with healthcare peers?
Ans. Granules India Share Price sits below the rich multiples of Divi’s Laboratories and Torrent Pharmaceuticals, but above Zydus Lifesciences on P/E. Its ROE and ROCE are solid, though not the highest in the peer set.
Should investors track Granules India Share Price on Univest?
Ans. Yes, investors tracking Granules India Share Price can use Univest for live price, valuation ratios, sector context and peer comparison. That helps connect the latest decline with longer-term financial context.
